Publications by authors named "P Priester"

Claim this Profile
B
Baseline and early changes in eosinophil count and neutrophil-to-eosinophil ratio predict outcomes in metastatic renal cell carcinoma treated with nivolumab.
Ondřej Fiala, Katarína Rejleková, Tomas Buchler, Hana Študentová, Alexandr Poprach, Peter Priester

Sci Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of concomitant use of proton pump inhibitors or cardiovascular medication on survival outcomes of patients with metastatic renal cell carcinoma treated with nivolumab.
Ondřej Fiala, Petr Hošek, Michaela Tkadlecová, Bohuslav Melichar, Anežka Zemánková, Peter Priester

Clin Exp Metastasis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Kinase Domain Duplication as a Potential On-Target Resistance Mechanism After Dabrafenib-Trametinib Therapy in a Patient With -Mutated Lung Adenocarcinoma.
Pierre de Priester, Lodovica Zullo, Damien Vasseur, Beatriz Alonso De Castro, Arianna Marinello

JCO Precis Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Immunological Alertness and Response to COVID-19 Vaccination-Conditions for Prevention in Early Palliative Oncological Care Patients.
Peter Priester, Miroslav Fajfr, Veronika Molnarova, Radek Sleha, Sylva Janovska

Vaccines (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sipping as a Nutritional Supplement in Ambulatory Palliative Oncology Care: A Pilot Study with Noninvasive Methods.
Alena Ticha, Radomir Hyspler, Veronika Molnarova, Peter Priester, Adela Tomasova

J Med Food· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis